F&F - Financial Insights SEC Filing Analytics

Financial Metrics

MDLN Medline Inc.
Range: 2023-01-01 to 2026-04-09

Regulatory Activity

Since 2025-04-09
Insider Filings (Forms 3/4/5)
9
Material Event Filings (8-K)
0
Type Form Filed Document
Insider 4 2026-03-12 SEC Filing Index
Insider 4 2026-03-06 SEC Filing Index
Insider 3 2026-03-06 SEC Filing Index
Insider 3 2026-02-23 SEC Filing Index
Insider 4 2026-02-13 SEC Filing Index

Credit and Bond Coverage

Company-level
Credit Ratings: SEC EDGAR does not provide a standardized, machine-readable issuer credit rating feed.
Integrate Moody's, S&P, or Fitch licensed data separately if ratings are required.
Long-Term Debt (latest annual)
12484000000.0
Total Liabilities (latest annual)
19198000000.0
Current Liabilities (latest annual)
2490000000.0
10-Q/10-K Files
Displays percentage-change badges below each chart in green/red.

Income Statement

Metrics: 6

Revenue

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 23231000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 25507000000.0 +9.8% USD 10-K 2026-02-25
Annual 2025-12-31 28432000000.0 +11.5% USD 10-K 2026-02-25

Gross Profit

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 5885000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 6976000000.0 +18.5% USD 10-K 2026-02-25
Annual 2025-12-31 7518000000.0 +7.8% USD 10-K 2026-02-25

Operating Income

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 1250000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 2146000000.0 +71.7% USD 10-K 2026-02-25
Annual 2025-12-31 2212000000.0 +3.1% USD 10-K 2026-02-25

Net Income

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 -7000000.0 USD 10-K 2026-02-25

EPS Basic

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 -0.01 USD/shares 10-K 2026-02-25

EPS Diluted

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 -0.01 USD/shares 10-K 2026-02-25

Balance Sheet

Metrics: 9

Cash and Equivalents

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 199000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 1939000000.0 +874.4% USD 10-K 2026-02-25

Accounts Receivable

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 3219000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 3533000000.0 +9.8% USD 10-K 2026-02-25

Inventory

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 4456000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 4769000000.0 +7.0% USD 10-K 2026-02-25

Current Assets

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 8272000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 10679000000.0 +29.1% USD 10-K 2026-02-25

Total Assets

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 35978000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 38484000000.0 +7.0% USD 10-K 2026-02-25

Current Liabilities

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 2440000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 2490000000.0 +2.0% USD 10-K 2026-02-25

Total Liabilities

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 19454000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 19198000000.0 -1.3% USD 10-K 2026-02-25

Stockholders' Equity

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 10737000000.0 USD 10-K 2026-02-25

Long-Term Debt

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 16416000000.0 USD 10-K 2026-02-25
Annual 2025-12-31 12484000000.0 -24.0% USD 10-K 2026-02-25

Cash Flow

Metrics: 4

Operating Cash Flow

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 1685000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 1769000000.0 +5.0% USD 10-K 2026-02-25
Annual 2025-12-31 1744000000.0 -1.4% USD 10-K 2026-02-25

Investing Cash Flow

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 -312000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 -1493000000.0 -378.5% USD 10-K 2026-02-25
Annual 2025-12-31 -474000000.0 +68.3% USD 10-K 2026-02-25

Financing Cash Flow

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 -191000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 -1613000000.0 -744.5% USD 10-K 2026-02-25
Annual 2025-12-31 399000000.0 +124.7% USD 10-K 2026-02-25

Capital Expenditures

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 275000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 354000000.0 +28.7% USD 10-K 2026-02-25
Annual 2025-12-31 447000000.0 +26.3% USD 10-K 2026-02-25

Share Data

Metrics: 4

Shares Outstanding

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Shares Issued

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Weighted Avg Shares Basic

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 809688877.0 shares 10-K 2026-02-25

Weighted Avg Shares Diluted

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 809688877.0 shares 10-K 2026-02-25
For informational purposes only — not guaranteed to be accurate or complete.